IVF vs SPHL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

IVF

37.8
AI Score
VS
SPHL Wins

SPHL

42.8
AI Score

Investment Advisor Scores

IVF

38score
Recommendation
SELL

SPHL

43score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric IVF SPHL Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 16.7% 5.8% IVF
Earnings Growth 0.0% -6.9% IVF
Tradestie Score 37.8/100 42.8/100 SPHL
Profit Margin -70.2% -30.1% SPHL
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD SPHL

Relative Price Performance (Last 90 Days)

IVF 1M: +3.9% · 3M: -32.9% SPHL 1M: -1.5% · 3M: -1.1%

Current Technical Phase

IVF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.8 · Price: $1.06

SPHL

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.6%), weak momentum, RSI 44

RSI (14): 44.1 · Price: $2.58

Fundamentals Snapshot

Metric IVF SPHL
Market Cap
Forward P/E -0.1 0.0
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth 0.2% 0.1%
Gross Margin 0.4% 0.1%
Operating Margin -0.6% -0.5%
EPS 353.17 -0.16
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SPHL is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.